Top news from MedWatch this week
Monday
Amgen to free up time and capacity with new Danish-Norwegian management team
Catalent behind Novo Nordisk’s supply issues, says media
Tuesday
Olympus designates three focus areas for its endoscopy business
Gates Foundation awards women’s health grant to life science incubator firm – new CIO hired
Estron’s CEO steps down – hunt for replacement has begun
Danish notified medtech body expected approved in 2023
Wednesday
Bioinnovation Institute wants to boost women’s health research: ”It hasn’t been prestigious enough”
EU Commission to consider medtech industry’s recruitment challenges
Thursday
Leo Pharma and Astrazeneca keep future plans tight for tralokinumab
Ascendis Pharma’s growth hormone formally approved in the EU
Demant gets FDA green light for new bone-anchored hearing solution
Bioinnovation Institute reaches DKK 1bn milestone
Friday
Ten EMA initiatives will strengthen clinical research in Europe
Genmab CEO hopes for verdict in Johnson & Johnson arbitration soon
Ascendis to investigate new indications following EU approval
Novo Holdings lets billions of dollars flow, bets big on Chinese and US acquisitions
